Mucin-1
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain A; UniProt 1041–1097 Chain B; UniProt 1098–1152 | Fragment:SEA domain, N-terminal Non-standard monomer:Yes (specific site not provided by mmCIF) Fragment:SEA domain, C-terminal Non-standard monomer:Yes (specific site not provided by mmCIF) | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;Native crystals (see related entry) were used as seeds in a drop of 1:1 mix of the SeMet-derivative (9 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 1.75 M sodium chloride, 0.2 M ammonium sulfate). | Resolution 1.60 Å R-free 0.222 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 6BSB | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1SM3 CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE Deposited 1997-12-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain P
139–151(13 aa)
|
Not recorded | CD CADMIUM ION × 8 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 1.95 Å R-free 0.283 |
| 6BSC Crystal structure of the Mucin-1 SEA domain Deposited 2017-12-01 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1041–1097(57 aa)
Fragment:SEA domain, N-terminal
Chain B
1098–1152(55 aa)
Fragment:SEA domain, C-terminal
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;Drop was a 1:1 mix of protein (10 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 2.0 M sodium chloride)
|
Resolution 1.30 Å R-free 0.184 |
| 6FZQ Crystal structure of scFv-SM3 in complex with compound 3 Deposited 2018-03-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
141–146(6 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 10 EEN 2-deoxy-2-[(difluoroacetyl)amino]-alpha-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.70 Å R-free 0.225 |
| 6FZR Crystal structure of scFv-SM3 in complex with compound 2 Deposited 2018-03-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
141–146(6 aa)
Fragment:UNP residues 141-146
|
Not recorded | EDO 1,2-ETHANEDIOL × 8 EEQ 2-deoxy-2-[(fluoroacetyl)amino]-alpha-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.80 Å R-free 0.232 |
| 6TGG scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar Deposited 2019-11-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
141–146(6 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 4 N8W ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 2.00 Å R-free 0.237 |
| 7Q4I Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP Deposited 2021-10-31 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain F
141–146(6 aa)
Chain G
141–146(6 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | UDP URIDINE-5'-DIPHOSPHATE × 2 EDO 1,2-ETHANEDIOL × 3 MN MANGANESE (II) ION × 2 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;potassium thiocyanate, Polyethylene glycol monomethyl ether 2,000
|
Resolution 2.40 Å R-free 0.235 |
| 7V4W Crystal structure of Antibody 16A in complex with MUC1 peptide Deposited 2021-08-15 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
145–157(13 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289 K;Di-sodium hydrogen phosphate 0.2M, PEG 3350 20%
|
Resolution 2.10 Å R-free 0.233 |
| 7V64 Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoT) Deposited 2021-08-19 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;1.0 M Lithium chloride, 0.1 M Tris pH 8.5, 20% PEG 6000
|
Resolution 1.56 Å R-free 0.203 |
| 7V7K Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoST) Deposited 2021-08-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;1.0 M Lithium chloride, 0.1 M Tris pH 8.5, 20%(w/v) PEG 6000
|
Resolution 2.20 Å R-free 0.251 |
| 7V8Q Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) Deposited 2021-08-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å R-free 0.244 |
| 7V8Q Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) Deposited 2021-08-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain H
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å R-free 0.244 |
| 7V8Q Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) Deposited 2021-08-23 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain I
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;289 K;Crystal screen D4=JCSG F7, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2-Propanol, 20% w/v Polyethylene glycol 4000
|
Resolution 3.20 Å R-free 0.244 |
| 7VAC Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) Deposited 2021-08-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å R-free 0.219 |
| 7VAC Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) Deposited 2021-08-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain H
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å R-free 0.219 |
| 7VAC Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) Deposited 2021-08-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain I
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 3.50 Å R-free 0.219 |
| 7VAZ Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) Deposited 2021-08-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
145–157(13 aa)
|
Not recorded | NGA 2-acetamido-2-deoxy-beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å R-free 0.264 |
| 7VAZ Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) Deposited 2021-08-30 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain E
145–157(13 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å R-free 0.264 |
| 7VAZ Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) Deposited 2021-08-30 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain I
145–157(13 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;0.1 M Sodium citrate pH 5.5, Isopropanol 10%, PEG 4000 20%
|
Resolution 2.73 Å R-free 0.264 |
| 8AXH Crystal structure of a MUC1-like glycopeptide containing the unnatural L-4-hydroxynorvaline in complex with scFv-SM3 Deposited 2022-08-31 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
141–146(6 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 6 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;PEG 3350
disodium hydrogen phosphate
|
Resolution 1.85 Å R-free 0.206 |
| 8P6I Crystal structure of the 139H2 Fab fragment bound to Muc1 peptide epitope Deposited 2023-05-26 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
141–149(9 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;0.2M NaCl
20%w/v PEG 8K
0.1M Na Phos Cit pH 4.2
|
Resolution 2.50 Å R-free 0.254 |
| 8P6I Crystal structure of the 139H2 Fab fragment bound to Muc1 peptide epitope Deposited 2023-05-26 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain a
141–149(9 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;0.2M NaCl
20%w/v PEG 8K
0.1M Na Phos Cit pH 4.2
|
Resolution 2.50 Å R-free 0.254 |
| 8S6K Crystal structure of ScFv-G2D11 complexed to a bis-Tn glycopeptide Deposited 2024-02-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain M
127–133(7 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 7 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;lithium chloride
Tris
PEG 8000
|
Resolution 1.75 Å R-free 0.221 |
| 8S6K Crystal structure of ScFv-G2D11 complexed to a bis-Tn glycopeptide Deposited 2024-02-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain N
127–133(7 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 5 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;291 K;lithium chloride
Tris
PEG 8000
|
Resolution 1.75 Å R-free 0.221 |
| 8S6T Crystal structure of Fab-3F1 complexed to a bis-STn glycopeptide Deposited 2024-02-28 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain C
126–138(13 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;Magnesium chloride hexahydrate
calcium chloride dihydrate
NDSB
sodium HEPES
MOPS
ethylene glycol
PEG 8000
|
Resolution 1.85 Å R-free 0.267 |
| 8S6V Crystal structure of Fab-2D9 chimera complexed to a bis-Tn glycopeptide Deposited 2024-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain M
127–135(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 4 SO4 SULFATE ION × 2 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291 K;lithium sulfate
Bis-Tris
PEG 3350
|
Resolution 1.95 Å R-free 0.244 |
| 8S6V Crystal structure of Fab-2D9 chimera complexed to a bis-Tn glycopeptide Deposited 2024-02-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain N
127–135(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | EDO 1,2-ETHANEDIOL × 7 SO4 SULFATE ION × 3 A2G 2-acetamido-2-deoxy-alpha-D-galactopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291 K;lithium sulfate
Bis-Tris
PEG 3350
|
Resolution 1.95 Å R-free 0.244 |
17 other PDB entries and 26 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | MUC1_HUMAN |
| Isoform | — |
| PDB entities | 1, 2 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–57; UniProt 1041–1097 Author chain B; PDBConstruct 1–55; UniProt 1098–1152 |